EADV Podcast

How did the pandemic enrich our knowledge about hair loss? What do we know about COVID-19 skin manifestations in children? Join us as we tackle these questions and dive into the subject of alopecia areata with renown expert Prof. Ramon Grimalt, including current therapeutic landscape, new technologies and consensus recommendations for clinical trials.

In a recent webcast, EADV President and dermatovenereologist Prof. Alexander Stratigos highlighted the educational opportunities and economic benefits being offered to members of the academy and disclosed some of the plans for the next years to support continuing medical education in the field.  Not an EADV Member? Click here for more information on the advantages and opportunities that only EADV...

Join us as we go through the JEADV Editor's Picks of February 2022: (1) Ischemia/reperfusion injury as a model of inflammatory skin diseases – role of IL-36R antagonis (2) Eruptive hemangiomatosis: another (self-limiting) reaction to a SARS-CoV-2 vaccine (3) Do parents feel guilty about their child’s atopic dermatitis? (4) Janus-Kinase-Inhibitor effective in atopic dermatitis when a monoclonal ant...

What do we know about the transmission of herpes and treatment options for herpes? Antiviral suppression? What about catamenial occurrences? Join us as we explore the subject with Dr Peter Greenhouse.   The audio from this podcast came from an EADV Webcast titled:  Anogenital Warts and Genital Herpes: Myths and Management EADV Members can access the whole webcast at here. Not an EADV Member? Click...

This week Prof. Christos Zouboulis from the Dessau Medical Center interviews Bente Villumsen, the President of the Patientforeningen HS Danmark (Danish Hidradenitis Suppurativa Patient Association). They discuss the importance of increasing disease awareness, availability of reliable medical information incorporating the patient perspective and establishing a meaningful cooperation between patient...

Join us as we go through the JEADV Editor's Picks of January 2022: (1) Dermatologic origin of a fatal C. ciferrii systemic infection (2) Emollient use in hot environments among neonates for eczema prevention: how much is enough? (3) Non-invasive visualization of human skin (4) Acute self-limiting erythema multiforme after SARS-CoV-2 vaccination Read the Editor's Picks here: https://onlinelibrary.w...

This week JEADV Clinical Practice Editor-in-Chief Dr. Antonio Torrelo talks about his three decades of experience in Paediatrics Dermatology, highlighting the most important skills and challenges of treating children with skin diseases. Moreover, Dr. Torrelo shares some key facts about JEACP and reveals how a day in the life of the Editor of EADV's new Open Access journal looks like. Visit https:/...

This week Prof. Ashraf Badawi covers more topics connected with challenging situations in cosmetic dermatology. In this second episode of a two-part- series he discusses laser and light-based therapies and injectables in autoimmune diseases, particularly Lupus and considers how to, and when not to, treat patients with psychological disorders seeking aesthetic procedures. He brings practical clinic...

Join us as we go through the JEADV Editor's Picks of December 2021: (1) Skin conditions affect politicians too (2) Evaluating a chemical peel, non-invasively (3) SARS-CoV-2 transmission via sweat: searching for evidence (4) Undertreatment of scabies Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17763

Could better understanding of the role of autoantibodies hold the key to personalised treatments in itchy and blistering diseases?   This week we bring together experts Prof. Kridin and Dr. Meijer to discuss their recent JEADV publications concerning the role of autoantibodies in itchy and blistering diseases. Prof. Kridin talks about the pathophysiology and therapeutic approaches to treat patient...

Should you stop an anticoagulant for thrombosis to prevent bruising after cosmetic procedures? What changed during the pandemic? Can ablative laser plumes harm operating room personnel? This week Prof. Ashraf Badawi discusses challenging situations that can arise in cosmetic dermatology. He brings practical clinical experience as well as the current research to the discussion.   Not an EADV Member...

Join us as we go through the JEADV Editor's Picks of November 2021: (1) Long-term safety data for a monoclonal antibody used in psoriasis (2) Preventing anaphylactoid symptoms following Covid-19 vaccination (3) Innovative surgery option for bromhidrosis  (4) Surprising trends in syphilis Read the editor's picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17691

This week EADV Advocacy Working Group Leader Myrto Trakatelli talks with Stella Siskou about topics including EPIDERM, the EADV Advocacy Working Group, and a position paper on the role of dermatologists in the evolving field of Dermato-oncology.   The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV–UEMS and EORTC C...

This week Dr. Mark Lebwohl from Icahn School of Medicine at Mount Sinai joins us to discuss the latest treatment options for psoriasis and his research focusing on new topical therapies for the management of the disease.   Links to the six articles discussed can be found here: Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 2...

Join us as we go through the JEADV Editor's Picks of October 2021: (1) Are skin types equally represented in Scandinavian dermatology textbooks? (2) Apremilast for palmoplantar pustulosis under study (3) The link between autoimmune bullous diseases and neurological diseases (4) Investigating the cancer risk of using a biologic drug in atopic dermatitis Read the editor's picks here: https://onlinel...

This week esteemed Professor Branka Marinović shares her experience as Secretary General of the EADV (2017-2021) and reflects on some significant ways how the Academy has changed in the past years. Join us as Prof. Marinovic talks about how the “Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus” facilitated the everyday work of Dermatologists and improved quality of care...

This month we discuss a recent publication reporting on the success of a targeted skin cancer screening initiative at a sailing festival with author Professor Khosrotehrani, a clinician-scientist and dermatologist at the University of Queensland, and the Diamantina Institute, Brisbane. Listen as moderator Dr Sarah Walsh explores the challenges and implications of delivering such a screening progra...

Join us as we go through the JEADV Editor's Picks of September 2021: (1) Promising debut for a new botulinum toxin (2) Does atopic dermatitis impact future education levels? (3) Beyond histamine: itch in scabies (4) Mental health and treatment response of anogenital warts: a prospective study Read the editor's picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.17528

In the run-up to the 30th Congress of the European Academy of Dermatology and Venereology, Prof Alexander Stratigos, talks about the accomplishments of the Academy in his first year as President and the challenges and opportunities brought about by the COVID-19 pandemic that have paved the way to a digital transformation and a strengthened voice in Europe.

Lichen Planus and Lichen sclerosus are two conditions that affect the vulva. Due to popular request, this week we will revisit the a webcast where Dr Fiona Lewis brings practical clinical experience focusing on diagnosis and basic management of these conditions.

Join us as we go through the JEADV Editor's Picks of August 2021: (1) Genetic advances in treating epidermolysis bullosa (2) Searching for a tolerable topical treatment of primary axillary hyperhidrosis (3) RASopathies and the importance of skin examinations (4) Molecular testing of tinea Read the Editor's Picks here

Early detection of skin cancer is still a major challenge in dermatology practice today. While surveillance programs are offered to high-risk patients, systematic total-body examination in the general population is not cost-effective. Lesion-directed screening may be a way to optimise skin cancer detection in the general population and use available time as efficient as possible in daily dermatolo...

We have a vast amount of research about the impact of UVB, UVA, visible light and infrared radiation on skin and subsequent dermatoses. We also have extensive information and research on how to mitigate risk from sun exposure. Yet, how do we communicate this to a public that doesn't often look much beyond the SPF number on a bottle of sunblock? Dr Elena Rossi explores this topic with Prof. Thierry...

Join us as we go through the JEADV Editor's Picks of July 2021: (1) Novel presentation of pigtail hairs (2) Seeing the light: moving past sun protection factor and ultraviolet B when choosing sunscreen (3) Antifungal resistance may be spreading in Europe (4) Agreeing on the correct histopathologic diagnosis of melanoma Read the Editor's picks here: https://www.onlinelibrary.wiley.com/doi/10.1111/j...

In a digital world, are you ready to adjust, evolve and stay ahead of the curve when it comes to offering a state-of-the-art experience to your patients and improving their quality of life? Digitalization has made tremendous progress during the COVID pandemic; it is here to stay and its impact is already visible on (tele)dermatology. Join today’s discussion between Prof. Jan Gutermuth (University...